Literature DB >> 10224222

Regulation of matrix metalloproteinase expression in tumor invasion.

J Westermarck1, V M Kähäri.   

Abstract

Degradation of basement membranes and stromal extracellular matrix (ECM) is crucial for invasion and metastasis of malignant cells. Degradation of ECM is initiated by proteinases secreted by different cell types participating in tumor cell invasion, and increased expression or activity of every known class of proteinases (metallo-, serine-, aspartic-, and cysteine) has been linked to malignancy and invasion of tumor cells. Studies performed over the last decade have revealed that matrix metalloproteinases (MMPs) play a crucial role in tumor invasion. Expression of MMP genes is transcriptionally regulated by a variety of extracellular factors including cytokines, growth factors, and cell contact to ECM. This review will summarize the current view on the role of MMPs in tumor growth, invasion, and survival, and focus on the role of mitogen-activated protein kinases and AP-1 and ETS transcription factors in the regulation of MMP gene expression during invasion process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10224222

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  367 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Comparison of metalloproteinase protein and activity profiling.

Authors:  Orsi Giricz; Janelle L Lauer; Gregg B Fields
Journal:  Anal Biochem       Date:  2010-10-23       Impact factor: 3.365

3.  Localization of CD44 and CD90 positive cells to the invasive front of breast tumors.

Authors:  Vera S Donnenberg; Albert D Donnenberg; Ludovic Zimmerlin; Rodney J Landreneau; Rohit Bhargava; Ryan A Wetzel; Per Basse; Adam M Brufsky
Journal:  Cytometry B Clin Cytom       Date:  2010-04-30       Impact factor: 3.058

Review 4.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

Review 5.  New insights into Nm23 control of cell adhesion and migration.

Authors:  Henri-Noël Fournier; Corinne Albigès-Rizo; Marc R Block
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

6.  Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9.

Authors:  Heesang Song; Yonghe Li; Jiyeon Lee; Alan L Schwartz; Guojun Bu
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

Review 7.  Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

8.  Relationship between matrix metalloproteinase 2 and lung cancer progression.

Authors:  Chun-Bao Guo; Shan Wang; Chun Deng; Dian-Liang Zhang; Fu-Ling Wang; Xian-Qing Jin
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

9.  Inhibitory effects of c9, t11-conjugated linoleic acid on invasion of human gastric carcinoma cell line SGC-7901.

Authors:  Bing-Qing Chen; Yan-Mei Yang; Yan-Hui Gao; Jia-Ren Liu; Ying-Ben Xue; Xuan-Lin Wang; Yu-Mei Zheng; Jing-Shu Zhang; Rui-Hai Liu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 10.  Metalloproteinases and plasminogen activators in vessel remodeling.

Authors:  Alex Bobik; Vselovod Tkachuk
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.